Table 1.
Patient characteristics at baseline
| AHC (n = 68) | CHC (n = 11) | |
|---|---|---|
| Epidemiological characteristics | ||
| Sex (male, %) | 50 (73.5) | 10 (90.9) |
| Age (years) | 55.6 ± 11.5 | 54.1 ± 10.0 |
| Hemodialysis (n, %) | 68 (100) | 11 (100) |
| HBV co‐infection | 7 (10.3) | 2 (18.2) |
| HCV infection parameters | ||
| Genotype, 1b | 68 (100) | 11 (100) |
| HCV‐RNA (log IU/ml) | 5.6 ± 1.4 | 5.1 ± 1.0 |
| Anti‐HCV (+) | 40 (58.8) | 11 (100) |
| Laboratory parameters | ||
| Hb (g/L) | 104.1 ± 21.8 | 96.0 ± 15.1 |
| PLT (×109/L) | 167.8 ± 54.2 | 149.0 ± 30.2 |
| Albumin (g/L) | 40.0 ± 5.0 | 38.4 ± 6.1 |
| ALT (U/L) | 69.6 ± 99.7 | 39.6 ± 38.2 |
| AST (U/L) | 36.8 ± 47.1 | 22.9 ± 15.8 |
| Bilirubin (μM) | 8.0 ± 5.6 | 7.2 ± 3.5 |
| Urea nitrogen | 23.8 ± 7.4 | 27.8 ± 12.1 |
| Creatinine (μM) | 943.8 ± 274.5 | 1130.3 ± 206.7 |
Abbreviations: AHC, acute hepatitis C; ALT, alanine transaminases; AST, aspartate aminotransferase; CHC, chronic hepatitis C; HBV, hepatitis B virus; HCV, hepatitis C virus; Hb, hemoglobin; PLT, platelet; TBIL, total bilirubin.